| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Sierra Oncology Inc. | 130,798 | 200,000 | 0.08% | ||
| 2 | ALCOBRA LTD | 185,140 | 211,000 | 0.09% | ||
| 3 | ADVERUM BIOTECHNOLOGIES INC | 280,000 | 756,000 | 0.31% | ||
| 4 | OCERA THERAPEUTICS INC | 1,217,872 | 1,595,000 | 0.65% | ||
| 5 | KALVISTA PHARMACEUTICALS INC | 221,651 | 1,635,000 | 0.67% | ||
| 6 | LIPOCINE INC NEW | 420,000 | 1,638,000 | 0.67% | ||
| 7 | STEMLINE THERAPEUTICS INC | 228,130 | 1,951,000 | 0.80% | ||
| 8 | COHERUS BIOSCIENCES INC COM | 95,276 | 2,015,000 | 0.82% | ||
| 9 | ARCA biopharma Inc | 1,078,932 | 2,751,000 | 1.13% | ||
| 10 | AKARI THERAPEUTICS PLC | 369,490 | 4,090,000 | 1.67% | ||
| 11 | ACCELERON PHARMA INC | 156,880 | 4,153,000 | 1.70% | ||
| 12 | CYTOMX THERAPEUTICS INC COM | 288,915 | 4,990,000 | 2.04% | ||
| 13 | Axovant Sciences LTD | 429,590 | 6,418,000 | 2.63% | ||
| 14 | Audentes Therapeutics, Inc. | 458,882 | 7,819,000 | 3.20% | ||
| 15 | RA PHARMACEUTICALS INC COM | 725,029 | 15,436,000 | 6.32% | ||
| 16 | EDGE THERAPEUTICS INC | 1,933,582 | 17,615,000 | 7.21% | ||
| 17 | DBV Technologies | 373,617 | 18,683,000 | 7.64% | ||
| 18 | Ascendis Pharma | 811,492 | 22,722,000 | 9.30% | ||
| 19 | BIOCRYST PHARMACEUTICALS | 6,071,142 | 50,998,000 | 20.87% | ||
| 20 | AVEXIS INC COM | 1,035,657 | 78,741,000 | 32.22% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-004811, filed 2017.05.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
